The Enterprise Value as of April 2026 (TTM) for Aileron Therapeutics, Inc. (ALRN) is 34.64M

According to Aileron Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 34.64M. This represents a change of 79.56% compared to the average of 19.29M of the last 4 quarters.

Aileron Therapeutics, Inc. (ALRN) Historical Enterprise Value (quarterly & annually)

How has ALRN Enterprise Value performed in the past?

The mean historical Enterprise Value of Aileron Therapeutics, Inc. over the last ten years is 4.98M. The current 34.64M Enterprise Value has changed 69.52% with respect to the historical average. Over the past ten years (40 quarters), ALRN's Enterprise Value was at its highest in in the December 2024 quarter at 37.03M. The Enterprise Value was at its lowest in in the December 2016 quarter at -20715000.00.

Aileron Therapeutics, Inc. (ALRN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aileron Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aileron Therapeutics, Inc. (ALRN) Average Enterprise Value

How has ALRN Enterprise Value performed in the past?

The current Enterprise Value of Aileron Therapeutics, Inc. (ALRN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aileron Therapeutics, Inc. (ALRN) Enterprise Value vs. Peers

How is ALRN’s Enterprise Value compared to its peers?

Aileron Therapeutics, Inc.’s Enterprise Value is less than Lunai Bioworks Inc. (35.18M), greater than Magenta Therapeutics, Inc. (-7259976.00), less than GreenLight Biosciences Holdings (57.81M), less than Pluristem Therapeutics Inc. (43.01M), greater than AlloVir, Inc. (6.26M), less than Spyre Therapeutics, Inc. (4.41B), less than bluebird bio, Inc. (158.07M), greater than Kronos Bio, Inc. (-13835104.00), greater than ERYTECH Pharma S.A. (3.80M), greater than Lumos Pharma, Inc. (3.04M),

Build a custom stock screener for Aileron Therapeutics, Inc. (ALRN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aileron Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aileron Therapeutics, Inc. (ALRN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aileron Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.